Dr. Gregory Bailly attended Queen’s University, completing a BSc in Life Sciences in 1993, before returning to his home province to complete Medical School at Dalhousie University in 1997. He subsequently completed his urology residency at Dalhousie in 2002 and was appointed chief as of July 2018. Dr. Bailly completed a Fellowship at the University of Toronto in Urodynamics and Reconstructive Urology, before joining the Department of Urology at Dalhousie University in 2003. Dr. Bailly has focused his academic interest on resident education, serving as the Program Director since 2006. Dr. Bailly’s clinical interests include female urology, incontinence, urethral reconstruction, erectile dysfunction and prostate disease.

Dr. David Bell is a native Nova Scotian, born in Liverpool, NS. He completed his undergraduate and medical degrees at Dalhousie University. He fulfilled his internship at St. Paul's Hospital in Vancouver and following a year of Primary Care returned to complete a Urology residency at Dalhousie University. He completed further Fellowship training in Urologic Oncology at Laval University and at the Indiana University Medical Centre, Indianapolis, Indiana and joined the Faculty of Medicine at Dalhousie in 1992. Dr David G. Bell was appointed Professor and Department Head for the Department of Urology in 2008 adn served until 2018. Dr Bell has a major interest in Urologic Oncology with a primary interest in bladder and prostate cancer.

Dr. Dawn MacLellan completed a Bachelor of Science degree, medical school and Urology residency training at Dalhousie University. She spent three years as a fellow at the Boston Children’s Hospital performing clinical and basic science research in pediatric urology. Dr. MacLellan was appointed as Assistant Professor to the Department of Urology at Dalhousie University in 2004. She was cross-appointed to the Department of Pathology and Faculty of Graduate Studies in 2006. Her current interests are the clinical care of children with urologic disease and clinical and basic science research in the pathophysiology of kidney obstruction and other congenital anomalies.

Dr. Ricardo A. Rendon is a native of Colombia. He completed medical school training in 1993 at the Universidad Javeriana in Bogota, Colombia. Subsequently, he completed a rotating internship and Urology residency at Universidad Javeriana in Bogota. Dr Rendon arrived in Canada to complete a two year Research and Clinical Fellowship in Urologic Oncology at the Princess Margaret Hospital and University of Toronto. He is in the process of obtaining a MSc in Community Health and Clinical Epidemiology at Dalhousie University. Dr. Rendon obtained his Fellowship of the Royal College of Physicians and Surgeons of Canada in 2007. He is presently an Associate Professor with the Department of Urology at Dalhousie University and his research interests include kidney cancer and urothelial cell carcinoma as well as other urologic malignancies. He is the Director of the Department of Urology Clinical Trials Unit and the Chair of the Department of Urology Research Committee.

Dr. Andrea Lantz Powers is originally from British Columbia, but moved to Nova Scotia with her family after high school. Most of her immediate and extended family lives in the South shore area. Andrea completed her B.Sc. at Saint Mary’s University then medical school at Dalhousie University. She went on to Urology residency in Ottawa and  finished fellowship training in Toronto at St. Michael’s hospital. Andrea was drawn to Urology after completing her clerkship rotation at the QEII as a medical student. 
Dr. Ashley Cox is originally from Toronto and completed an undergraduate degree at McMaster University in 2001. She attended medical school at the University of Western Ontario before completing urology residency training at Dalhousie University. She returned to Ontario for two years to complete fellowship training in Reconstructive and Female Urology. She recently completed a Masters degree in Clinical Epidemiology & Health Care Research at the University of Toronto.   Throughout residency she fell in love with the city of Halifax and is excited to call it home.

Dr. Ross Mason completed a Bachelor of Science in Chemistry (first class honors) before attending Dalhousie University for Medical School and a residency in Urology. He subsequently completed a Society of Urologic Oncology accredited fellowship in Urologic Oncology at the Mayo Clinic in Rochester, Minnesota where he also completed a Master’s Degree in Clinical and Translational science. His clinical and research interests include all aspects of urologic oncology with a particular focus on malignancies of the kidney, prostate, and bladder. 

Dr. Tom McGregor began his medical training in eastern Ontario, completing medical school at the University of Ottawa in 2004 and then his urology residency at Queen's University in 2009. He then went on to complete a two year fellowship in renal transplantation and minimally invasive surgery at the University of Western Ontario in 2011. From there he was recruited to the University of Manitoba where he introduced laparoscopic donor surgery and helped expand a reputable living kidney donor program. While at the University of Manitoba he was appointed to Urology Program Director as well as the Thorlakson Co-chair in Surgical Research. Following a successful stretch in Manitoba he was recruited back to Queen's University to expand the transplant program here and to bring minimally invasive donor surgery to Kingston, Ontario.  In setting up a successful Living Donor Program in Kingston, Dr. McGregor has received a Leadership Award for his efforts.  Both Winnipeg and Kingston now have very reputable Renal Transplant programs providing excellent care to patients in those regions.  Other achievements during his time at Queen's University was the initiation and set-up of a successful Robotic Renal Sugery program. 
The final leg of his medical journey has brought him to the east coast of Canada to join the Dalhousie Urology Team.   He hopes to help expand an already busy kidney transplant program as well as contribute his MIS and robotic skills to help treat patients in the region who suffer from renal pathology.
Dr. Daniel Keefe
Dr. Keefe joined the IWK Division of Pediatric Urology and Dalhousie Department of Urology in August 2021 after completing fellowship training at University of Toronto’s Hospital for Sick Children. Prior to this, he finished Urology training at the University of Ottawa, and medical school at Dalhousie University. He is in the process of completing a MSc in System Leadership and Innovation at the University of Toronto.
Dr. Keefe was born and raised in Prince Edward Island and is looking forward to providing care for patients from across Atlantic Canada. He has a clinical interest in caring for the entire spectrum of conditions in pediatric urology with a focus on kidney stone management, urinary tract obstruction, and pediatric renal transplantation. His academic interests include medical education, applications of artificial intelligence in urology, and urinary tract obstruction.
Dr. Jesse Ory
Dr Ory grew up in Victoria, BC and moved to Halifax in 2015 to pursue his residency in Urology. After completing his residency, he went to the University of Miami for a 1-year fellowship in infertility and andrology, while also working with the endourology team to develop skills in HoLEP. He joined the Department of Urology at Dalhousie in 2021 in a locum position. He is passionate about surgical education and mentoring the next generation of healthcare professionals. His academic interests focus around testosterone therapy, fertility preservation, and varicocele repair.  
Dr. Jon Duplisea
Dr. Duplisea grew up in Saint John, New Brunswick.  He completed medical school in Newfoundland at Memorial University.  He completed residency at Dalhousie University.  Following this, he completed a Society of Urologic Oncology accredited fellowship at The University of Texas MD Anderson Cancer Center in Houston, Texas.  He joined the Department of Urology in 2019.
Dr. Jon Moore
Dr. Moore completed his Undergraduate degree, Medical School, and Urology Residency training all through Dalhousie University.  Following residency, he completed fellowship in Endourology and Laparoscopic/Robotic Fellowship at the Mayo Clinic in Phoenix, Arizona. From there he began work as Assistant Professor in the Department of Urologic Surgery at UC Davis in Sacramento, California. He focuses clinically on the comprehensive medical and surgical treatment of general urological conditions. He has a particular interest in patients with recurrent kidney stones, acute kidney stone attacks, and BPH. He returns with his wife, dog and two kids. They are all very excited to be coming back to the Maritimes and to join the Department of Urology at Dal.
Dr. Nick Paterson
Dr. Nick Paterson spent over a decade in Ottawa from medical school through to the end of fellowship. There he completed his urology residency and a two-year fellowship specializing in minimally invasive and robotic surgery, renal transplant, and complex stone disease. He concurrently achieved his masters through the University of Toronto’s Institute of Health Policy, Management and Evaluation. During that time, he worked closely with Health Canada’s Organ Donation and Transplant Collaborative to improve the efficiency of provincial living donation models.
His clinical interests include open, laparoscopic, and robotic renal and adrenal surgery as well as endoscopic and percutaneous stone surgery. His academic interests include quality improvement, medical education, and initiatives to expand access to living and deceased organ donation.
Dr. Andrea Kokorovic
Dr. Kokorovic is a urologic oncologist and a faculty member of the Department of Urology at Dalhousie University, She completed her fellowship in urologic oncology at the MD Anderson Cancer Center, and was an Assistant Professor/Urologist at the University of Montreal prior to accepting a position at Dalhousie University.
Her clinical and research interests include management of urologic cancers, with a focus on bladder, prostate, and kidney cancers. She is an active member of the Canadian Cancer Trials Group (CCTG) and is involved in numerous clinical trials for prostate and bladder malignancies. She is passionate about improving the lives of patients living with urological malignancies.